Editor's Highlights—May 2026

Early detection remains the most powerful intervention in cutaneous oncology, yet it depends on accurate recognition across very different clinical contexts-from rare, rapidly progressive neuroendocrine tumors to common melanocytic lesions that patients first notice at home. This month's selected articles span this spectrum, highlighting practical dermoscopic clues for Merkel cell carcinoma, pragmatic surgical decision-making for anatomically constrained sites, and emerging approaches to melanoma risk stratification and public education. Together, they underscore a single message: better outcomes require both sharper clinical pattern recognition and clearer, more personalized risk communication.